The U of Colorado-Boulder NR trial results have been released

The U of Colorado-Boulder NR trial results were released last week and showed promising results for those taking 1,000 mg of NR (Nicotinamide Riboside), a derivative of vitamin B3, a day for six weeks. (The Elysium study released last December suggests little increase in NAD+ levels above 500 mg a day, beyond eight weeks.)

First, it looks like NR improved flexiblity in the aurota among healthy non-obese people. Second, NR lowered the systoic blood pressure by an average of 10 points among those with pre-hypertension but not in adults aged 55 to 79 with normal blood pressure.

Chris Martens at the U of Delaware stated: “What this paper provides us with is a really good stepping stone for future work.”

The U of Colorado article also mentions that Martens is preparing a new trial on older adults with mild cognitive impairment.

Advertisements
This entry was posted in health, Health Pills and tagged , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s